18 studies were found.

1.		Recruiting	A Clinical Trial of Natalizumab in Individuals With Moderately to Severely Active Crohn’s Disease Condition: Crohn's Disease
2.		No longer recruiting	Combination Therapy with Avonex and BiMonthly High Dose Intravenous Methotrexate in Multiple Sclerosis Condition: Multiple Sclerosis
3.		Suspended	Dose Escalation Study to Determine the Safety of IFN-Beta Gene Transfer in the Treatment of Grade III & Grade IV Gliomas Conditions: Glioblastoma Multiforme; Anaplastic Astrocytoma; Oligoastrocytoma, Mixed; Gliosarcoma
4.		Recruiting	Effect of Rituximab on Immunological Recall Response to Specific Antigens in the Treatment of Non-Hodgkin’s Lymphoma Condition: Non-Hodgkin's Lymphoma
5.		Completed	An Escalating Dose Tolerance Trial of BG8962 (rCD4) in Patients Who Are HIV Antibody Positive Condition: HIV Infections
6.		Suspended	Gene Therapy in Treating Patients With Recurrent or Progressive Glioblastoma Multiforme Conditions: recurrent adult brain tumor; adult glioblastoma multiforme
7.		Recruiting	Natalizumab in the Treatment of Rheumatoid Arthritis in Subjects Receiving Methotrexate Condition: Rheumatoid Arthritis
8.		Terminated	A Phase II Trial of rsCD4 and AZT in Patients With AIDS or Advanced AIDS Related Complex (ARC) Condition: HIV Infections
9.		Recruiting	Rituximab/Fludarabine/Cyclophosphamide (FCR) versus Fludarabine/Cyclophosphamide (FC) Alone in the Treatment of Chronic Lymphocytic Leukemia (CLL) Condition: Chronic Lymphocytic Leukemia
10.		Completed	Safety and Efficacy of IDEC-114 in Combination with Rituxan in the Treatment of Non-Hodgkin's Lymphoma Condition: Non-Hodgkin's Lymphoma
11.		Recruiting	Safety and Efficacy of IDEC-152 in the Treatment of Chronic Lymphocytic Leukemia (CLL) Condition: Leukemia, Lymphocytic, Chronic
12.		No longer recruiting	Safety and Efficacy of Natalizumab in Combination with Avonex in the Treatment of Multiple Sclerosis Condition: Multiple Sclerosis
13.		No longer recruiting	Safety and Efficacy of Natalizumab in Combination with Remicade in the Treatment of Crohn’s Disease Condition: Crohn's Disease
14.		No longer recruiting	Safety and Efficacy of Natalizumab in the Treatment of Crohn's Disease Condition: Crohn's Disease
15.		No longer recruiting	Safety and Efficacy of Natalizumab in the Treatment of Crohn's Disease Condition: Crohn's Disease
16.		No longer recruiting	Safety and Efficacy of Natalizumab in the Treatment of Multiple Sclerosis Condition: Multiple Sclerosis, Relapsing-Remitting
17.		Recruiting	Safety and Efficacy of Zevalin in the Treatment of Non-Hodgkin's Lymphoma Condition: Non-Hodgkin's Lymphoma
18.		Completed	Safety, Tolerability and Effectiveness of Natalizumab in Adolescents with Active Crohn’s Disease Condition: Crohn's Disease